Markets

Market

News Details

(18/05/2026 21:00)

Sun Pharma Advanced posts Q4 net profit of Rs 1,760.70 cr

The company reported standalone net profit during the quarter stood at Rs 1,760.70 crore compared to net loss of Rs 60.98 crore in the previous year quarter.

Net revenue of the company declined substantially by 51.45 per cent at Rs 13.20 crore in January-March quarter of this fiscal as against Rs 27.19 crore in the corresponding period last year.

During January-March quarter, operating expenses dropped by 1.02 per cent to Rs 80.28 crore from Rs 81.11 crore in year ago period.

Other Income grew by 0.00 per cent at Rs 1.80 crore versus (Mar'25 Rs 0.00 crore).

Operating Profit surged by 3388.09 per cent to Rs 1,772.94 crore as against Rs -53.92 crore in the year ago period, while Operating Profit Margin (OPM) contracted year-on-year to 6872.91 per cent in March quarter.

Interest grew by 158.09 per cent y-o-y to Rs 11.64 crore

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.